ASP Isotopes publishes corporate deck outlining isotope enrichment growth strategy

ASP Isotopes

ASP Isotopes

ASPI

0.00

  • ASP Isotopes outlined plans to scale isotope enrichment capacity, expand product portfolio, improve unit economics, and accelerate commercialization through partnerships across electronics, nuclear medicine, and nuclear energy.
  • Operational targets include first shipments of enriched Silicon-28 in Q2 2026, initial Carbon-14 commercial shipments around mid-year subject to customer feedstock timing, and initial Ytterbium-176 shipments around mid-year/Q3.
  • Virginia Gas Project milestones call for helium Phase 1 nameplate capacity in Q3 2026, with Phase 1 output of about 2,500 GJ/day of LNG and 58 MCF/day of liquid helium.
  • Phase 2 expansion targets about 34,000 GJ/day of LNG and 900 MCF/day of liquid helium, positioned as roughly 7% of estimated global helium production.
  • Management set an EBITDA target of more than $300 million in 2031.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ASP Isotopes Inc. published the original content used to generate this news brief on May 12, 2026, and is solely responsible for the information contained therein.